Study of Binimetinib in Combination With Pembrolizumab in Advanced Non-Small Cell Lung Cancer

NCT03991819 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Non-small Cell Carcinoma

Interventions

DRUG: Binimetinib
DRUG: Pembrolizumab

Sponsor

University Health Network, Toronto